Effect of metformin on insulin-stimulated tyrosine kinase activity of erythrocytes from obese women with normal glucose tolerance

Diabetes and Metabolism

Volumn 23, Issue 2, 1997, Pages 143-148

  Santos, R F ^b   Nomizo, R ^b   Bopsco, A ^b   Wajchenberg, B L ^b   Reaven, G M ^a,c   Azhar, S ^a,c  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Erythrocytes; Insulin receptors; Kinase; Metformin; Obesity; Tyrosine

Indexed keywords

INSULIN; INSULIN RECEPTOR; METFORMIN; PROTEIN TYROSINE KINASE;

ADULT; ARTICLE; BODY WEIGHT; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; ISOTOPE LABELING; MAJOR CLINICAL STUDY; OBESITY; ORAL DRUG ADMINISTRATION;

ADULT; BLOOD GLUCOSE; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; KINETICS; METFORMIN; OBESITY; PROTEIN-TYROSINE KINASES; RECEPTOR, INSULIN;

EID: 0031002758     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Rossetti L, DeFronzo RA, Gherzi R et al. Effect of metformin treatment on insulin action in diabetic rats : in vivo and in vitro correlations. Metabolism, 1990, 39, 425-435.
2. Comi RJ, Grunberger G, Gorden P. Relationship of insulin binding and insulin-stimulated tyrosine kinase activity is altered in type II diabetes. J Clin Invest, 1987, 79, 453-462.
3. Santos RF, Palmieri MG, Wajchenberg BL, Azhar S. Insulin-receptor tyrosine kinase activity is decreased in erythrocytes from non-obese patients with NIDDM. Horm Metab Res, 1994, 26, 283-287.
4. Freidenberg GR, Henry RR, Klein HH, Reichart DR, Olefsky JM. Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J Clin Invest, 1987, 79, 240-250.
5. Sinha MK, Pories WJ, Flickinger EG, Meelheim D, Caro JF. Insulin-receptor kinase activity of adipose tissue from obese humans with and without NIDDM. Diabetes, 1987, 36, 620-625.
6. Thies RS, Molina JM, Ciaraldi TP, Freidenberg GR, Olefsky JM. Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese and NIDDM subjects. Diabetes, 1990, 39, 250-259.
7. Arner P, Lithell H, Livingston JN. Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia, 1987, 30, 437-440.
8. Caro JF, Sinha MK, Raju SM et al. Insulin receptor kinase in human skeletal muscle from obese subjects with and without non-insulin-dependent diabetes. J Clin Invest, 1987, 79, 1330-1337.
9. Caro JF, Ittoop O, Pories WJ et al. Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes : insulin action and binding in isolated hepatocytcs, insulin receptor structure, and kinase activity. J Clin Invest, 1986, 78, 249-258.
10. Santos RF, Nomizo R, Wajchenberg BL, Reaven GM, Azhar S. Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes. Diabete Metab, 1995, 21, 274-280.
11. Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest, 1987, 79, 1510-1515.
12. National Diabetes Data Group. Classification and diagnoses of diabetes mellitus and other categories of glucose intolerance. Diabetes, 1979, 28, 1039-1057.
13. Bailey CJ. Biguanides and NIDDM. Diabetes Care, 1992, 15, 755-767.
14. Kadish AH, Litle RL, Sternberg JC. A new and rapid method for determination of glucose by measurement of rate of oxygen consumption. Clin Chem, 1968, 14, 116-131.
15. Hales CN, Randle PJ. Immunoassay of insulin and insulin-antibody precipitate. Biochem J, 1963, 88, 137-146.
16. Grigorescu F, White MF, Kahn CR. Insulin binding and insulin-dependent phosphorylation of the insulin receptor solubilized from human erythrocytes. J Biol Chem, 1983, 258, 13708-13716.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976, 72, 248-254.
18. Harrison LC, Billington T, East IJ, Nichols RJ, Clark S. The effect of solubilization on the properties of the insulin receptor of human placental membranes. Endocrinology, 1978, 102, 1485-1495.
19. Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sci, 1949, 51, 660-672.
20. Munson PJ, Rodbard D. Ligand : a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem, 1980, 107, 220-239.
21. Reaven GM, Brand RJ, Chen Y-DI, Mathur AK, Goldfine I. Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals. Diabetes, 1993, 42, 1324-1332.
22. Jacobs DB, Hayes GR, Truglia JA, Lockwood DH. Effects of metformin on insulin receptor tyrosine kinase activity in rat adipocytes. Diabetologia, 1986, 29, 798-801.
23. Matthaej S, Reibold JP, Hamann A, Benecke H, Haring HH, Greten H, Klein HH. In vivo metformin treatment ameliorates insulin resistance : Evidence for potentiation of insulin-induced translocation and increased functional activity of glucose transporters in obese (fa/fa) Zucker rat adipocytes. Endocrinology, 1993, 133, 304-311.
24. Grigorescu F, Laurent A, Chanvanieu A, Capony JP. Cellular mechanism of metformin action. Diabete Metab, 1991, 17, 146-149.